Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration

Neuron

Volumn 35, Issue 3, 2002, Pages 433-446

  Higuchi, Makoto ^a   Ishihara, Takeshi ^a   Zhang, Bin ^a   Hong, Ming ^a   Andreadis, Athena ^b   Trojanowski, John Q ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL AGGREGATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; GENE OVEREXPRESSION; GLIA CELL; HUMAN; MOUSE; NERVE CELL; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0036685608     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(02)00789-4     Document Type: Article

References (65)

1. The distribution of tau in the mammalian central nervous system
2. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins)
3. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
4. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
5. Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns
6. Glial inclusions in CNS degenerative diseases
7. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
8. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice
9. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy
10. Cytoskeletal pathology in non-Alzheimer degenerative dementia: New lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration
11. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
12. Widespread cytoskeletal pathology characterizes corticobasal degeneration
13. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
14. Signature tau neuropathology in gray and white matter of corticobasal degeneration
15. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
16. Neuronal and glial DNA fragmentation in Pick's disease
17. The Tα-1 α-tubulin promoter specifies gene expression as a function of neuronal growth and regeneration in transgenic mice
18. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein
19. Tau gene mutation in familial progressive subcortical gliosis
20. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest tau human brain tau isoform
21. Tau filament formation in transgenic mice expressing P301L tau
22. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau
23. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
24. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
25. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites
26. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
27. Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells
28. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
29. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice
30. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics
31. Detection and quantitation of amyloid β-peptide with two monoclonal antibodies
32. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
33. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy
34. Epitopes that span the tau molecule are shared with paired helical filaments
35. Immunological and conformation characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease
36. Monoclonal antibodies to gel excised glial filament protein and their reactivity with other intermediate filament proteins
37. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
38. Neurodegenerative tauopathies
39. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
40. Connexin32 in oligodendrocytes and association with myelinated fibers in mouse and rat brain
41. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
42. Myelin degeneration in multiple system atrophy detected by unique antibodies
43. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases
44. Work Group on Frontotemporal Dementia and Pick's Disease. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease
45. Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy
46. Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain
47. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
48. Distinct pathological features of the Gallyas- and tau-positive glia in the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam
49. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration
50. Tau is a candidate gene for chromosome 17 frontotemporal dementia
51. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
52. Autosomal dominant dementia with widespread neurofibrillary tangles
53. Organization and functional roles of the cytoskeleton in oligodendrocytes
54. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
55. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
56. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
57. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
58. High tissue content of soluble Aβ1-40 linked to cerebral amyloid angiopathy
59. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location
60. The effects of aspartic acid-bond isomerization on in vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments
61. Over-expression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits
62. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein
63. Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue
64. Astrocytic straight tubules in the brain of a patient with Pick's disease
65. Sporadic Pick's disease: A tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter